Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Schallenberg

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
European Radiology|March 28, 2024
Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategiesCharlie A Hamm, Georg L Baumgärtner, Anwar R Padhani, et al.
Radiology|April 11, 2023
Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRICharlie A Hamm, Georg L Baumgärtner, Felix Biessmann, et al.
Cell|June 25, 2024
Open-ST: High-resolution spatial transcriptomics in 3DMarie Schott, Daniel León-Periñán, Elena Splendiani, et al.
European Urology Oncology|December 31, 2025
Multiregional Immune Profiling Reveals Prognostic Patterns in Bladder CancerNadia Jurczok, Gabriel Dernbach, Benedikt Ebner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2023
Artificial Intelligence-Based Tool for Tumor Detection and Quantitative Tissue Analysis in Colorectal SpecimensJohanna Griem, Marie-Lisa Eich, Simon Schallenberg, et al.
Molecular Medicine (Cambridge, Mass.)|April 2, 2022
Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancerTudor Moisoiu, Mihnea P Dragomir, Stefania D Iancu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2023
TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor gradingSimon Schallenberg, Gabriel Dernbach, Mihnea P Dragomir, et al.
Neoplasia (New York, N.Y.)|September 13, 2023
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancerInga Hoffmann, Mihnea P Dragomir, Nanna Monjé, et al.
Cell Systems|April 12, 2025
Combining spatial transcriptomics and ECM imaging in 3D for mapping cellular interactions in the tumor microenvironmentTancredi Massimo Pentimalli, Simon Schallenberg, Daniel León-Periñán, et al.
EMBO Molecular Medicine|May 2, 2026
Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinomaPhilipp Jurmeister, Susanne Flach, Linda Bergmayr, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
European Radiology|March 28, 2024
Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategiesCharlie A Hamm, Georg L Baumgärtner, Anwar R Padhani, et al.
Radiology|April 11, 2023
Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRICharlie A Hamm, Georg L Baumgärtner, Felix Biessmann, et al.
Cell|June 25, 2024
Open-ST: High-resolution spatial transcriptomics in 3DMarie Schott, Daniel León-Periñán, Elena Splendiani, et al.
European Urology Oncology|December 31, 2025
Multiregional Immune Profiling Reveals Prognostic Patterns in Bladder CancerNadia Jurczok, Gabriel Dernbach, Benedikt Ebner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2023
Artificial Intelligence-Based Tool for Tumor Detection and Quantitative Tissue Analysis in Colorectal SpecimensJohanna Griem, Marie-Lisa Eich, Simon Schallenberg, et al.
Molecular Medicine (Cambridge, Mass.)|April 2, 2022
Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancerTudor Moisoiu, Mihnea P Dragomir, Stefania D Iancu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2023
TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor gradingSimon Schallenberg, Gabriel Dernbach, Mihnea P Dragomir, et al.
Neoplasia (New York, N.Y.)|September 13, 2023
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancerInga Hoffmann, Mihnea P Dragomir, Nanna Monjé, et al.
Cell Systems|April 12, 2025
Combining spatial transcriptomics and ECM imaging in 3D for mapping cellular interactions in the tumor microenvironmentTancredi Massimo Pentimalli, Simon Schallenberg, Daniel León-Periñán, et al.
EMBO Molecular Medicine|May 2, 2026
Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinomaPhilipp Jurmeister, Susanne Flach, Linda Bergmayr, et al.
Pageof 8